Detection of relapse following allogeneic stem cell transplantation in AML:: NPM1-mutations precede the FLT3-LM/ITD and changes in chimerism

被引：0
|
作者：
Bacher, U. [1 ]
Badbaran, A. [1 ]
Fehse, B. [1 ]
Zabelina, T. [1 ]
Zander, A. R. [1 ]
Kroeger, N. [1 ]
机构：
[1] Univ Hamburg, Clin Stem Cell Transplant, Hamburg, Germany
来源：
ANNALS OF HEMATOLOGY | 2008年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [21] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    R Salem
    R Massoud
    B Haffar
    R Mahfouz
    A Bazarbachi
    J El-Cheikh
    Bone Marrow Transplantation, 2017, 52 : 1187 - 1190
  • [22] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    SalemRana, R.
    Massoud, R.
    Mahfouz, R.
    Bazarbachi, A.
    El-Cheikh, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S341 - S342
  • [23] Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
    Salem, R.
    Massoud, R.
    Haffar, B.
    Mahfouz, R.
    Bazarbachi, A.
    El-Cheikh, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 (08) : 1187 - 1190
  • [24] Immediate Allogeneic Hematopietic Stem Cell Transplantation for Patients with NPM1-Mutated AML in Molecular Relapse
    Schaefer-Eckart, Kerstin
    Wendelin, Knut
    Dressler, Sabine
    Gartner, Johannes
    Schneider, Lisa
    Thiede, Christian
    BLOOD, 2021, 138
  • [25] Immediate allogeneic blood stem cell transplantation for patients with NPM1-positive AML in molecular relapse
    Schaefer-Eckart, K.
    Wendelin, K.
    Gaertner, J.
    Thiede, C.
    Dressler, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 51 - 51
  • [26] Prolonged Remission of FLT3-ITD Positive AML Treated With Sorafenib Post Allogeneic Stem Cell Transplantation
    Moukadem, Hiba
    Antar, Ahmad
    Kharfan-Dabaja, Mohamed
    Bazarbachi, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S126 - S127
  • [27] Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations
    Yoon, Jae-Ho
    Kim, Hee-Je
    Jeon, Young-Woo
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    GENES CHROMOSOMES & CANCER, 2015, 54 (08): : 489 - 499
  • [28] Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome
    Jindra, Pavel
    Raida, Ludek
    Karas, Michal
    Szotkowski, Tomas
    Lysak, Daniel
    Hrabetova, Marcela
    Jungova, Alexandra
    Steinerova, Katerina
    Faber, Edgar
    Papajik, Tomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (07): : 462 - 469
  • [29] Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation
    Choschzick, Matthias
    Bacher, Ulrike
    Ayuk, Francis
    Lebeau, Annette
    JOURNAL OF CLINICAL PATHOLOGY, 2010, 63 (06) : 558 - 561
  • [30] A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics
    Huang, Qin
    Chen, Wengang
    Gaal, Karl K.
    Slovak, Marilyn L.
    Stein, Anthony
    Weiss, Lawrence M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (03) : 489 - 492
12345